Healthcare services

FNArena Windows (Sectors)

Introduction to FNArena Windows

FNArena Windows offers subscribers the option to investigate ASX-listed stocks against their peers. FNArena developed its own sector methodology which in our view overcomes many flaws and disadvantages connected with GICS sectors. Our system starts with three broad sector labels: COMMODITIES, FINANCIAL SERVICES and INDUSTRIALS. From here onwards subscribers can explore further through gradually narrowing branches. This is not investment advice, but simply another window on the Australian Stock Exchange to provide better insight and to assist FNArena subscribers while conducting their own market analysis.

Latest Stories

Brokers highlight deregulation and scale benefits from the potential merger of Integral Diagnostics and Capitol Health 

Jun 19 2024

Wrap of events affecting the market on Friday night and the weekend and a preview of the week ahead

Jun 17 2024


ASX CODE COMPANY NAME LAST PRICE 52WK HIGH 52WK LOW P/E CONSENSUS TARGET
ACL $3.50 $3.86 $2.15

$3.483

ALC ALCIDION GROUP LIMITED $0.06 $0.09 $0.04

$0.07

BMT ALCIDION GROUP LIMITED $0.25 $0.38 $0.17

$0.70

CAJ CAPITOL HEALTH LIMITED $0.36 $0.39 $0.21 1.1

$0.325

DOC DOCTOR CARE ANYWHERE GROUP PLC $0.06 $0.09 $0.04

$0.12

EBO EBOS GROUP LIMITED $33.75 $xx.xx $xx.xx xx.x xx.xx
HLS HEALIUS LIMITED $1.35 $xx.xx $xx.xx xx.x xx.xx
M7T MACH7 TECHNOLOGIES LIMITED $0.35 $xx.xx $xx.xx xx.x xx.xx
MDR MEDADVISOR LIMITED $0.29 $xx.xx $xx.xx xx.x xx.xx
MPL MEDIBANK PRIVATE LIMITED $3.70 $xx.xx $xx.xx xx.x xx.xx
MVF MONASH IVF GROUP LIMITED $1.13 $xx.xx $xx.xx xx.x xx.xx
NHF NIB HOLDINGS LIMITED $5.60 $xx.xx $xx.xx xx.x xx.xx
PSQ PACIFIC SMILES GROUP LIMITED $1.95 $xx.xx $xx.xx xx.x xx.xx
RHC PACIFIC SMILES GROUP LIMITED $39.05 $xx.xx $xx.xx xx.x xx.xx
SHL SONIC HEALTHCARE LIMITED $27.97 $xx.xx $xx.xx xx.x xx.xx
Previous Stories
Capitol Health’s Higher Margin Outlook

Mar 13 2024

Capitol Health’s first half results exceeded brokers’ expectations with higher margins thanks largely to stringent cost control


Treasure Chest: Ramsay Health Care

Oct 26 2023

FNArena’s Treasure Chest reports on money making ideas from stockbrokers and other experts. Today’s idea is on Ramsay Health Care


Timing Seems Right For Alcidion Group

Jun 21 2023

New research identifies Alcidion Group is attaining scale and becoming profitable at an opportune time for healthcare technology demand


No Enthusiasm To Combine ACL & Healius

Mar 21 2023

A takeover bid for Healius by Australian Clinical Labs has been greeted with very little enthusiasm, if any


Dr Boreham’s Crucible: Alcidion

Dec 13 2022

Tim Boreham highlights opportunities for SaaS company Alcidion, which tracks patients through the medical system


No Straight Covid-Relief For Ramsay Health Care

Nov 15 2022

Following first quarter results, some brokers anticipate rising margins for Ramsay Health Care though overseas operations are harder to forecast


Dr Boreham’s Crucible: Mach7 Technologies

Nov 14 2022

Medical imaging is back in demand in the post-covid world and Mach7 Technologies seems an undervalued player


Negative Industry Trends Impact Australian Clinical Labs

Aug 12 2022

FY22 results for Australian Clinical Labs missed expectations and brokers await an uptick in non-covid testing


Healius Offers Digital Carrot, Base Remains Soft

May 25 2022

Recovery in the core business remains important in the near-term for Healius, as benefits from covid testing look likely to soften in the remainder of the year, but longer-term digitisation remains a focus for the company


Ramsay Stakes Future on Mental Health

Dec 20 2021

Its latest acquisition has increased Ramsay Health Care’s exposure to the high growth mental health care segment, but potential opportunity has largely failed to impress analysts